Skip to main content
Livermore
Livermore
ZHEN

EagleClaw Capital Managment, LLC

SEC CIK
0001607636
Latest filing
Aug 10, 2026

ABT holding history

Abbott Laboratories in every 13F filed by EagleClaw Capital Managment, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABT overviewAll 13F holders of ABTFull Q2 2026 holdings

Shares (Q2 2026)
4,648
Value
$421.8K
% of portfolio
0.1%
Quarters held
22
Since Q1 2021
Holdings of ABT by EagleClaw Capital Managment, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20264,648$421.8K0.1%00.0%UnchangedHolders
Q1 20264,648$477.2K0.1%00.0%UnchangedHolders
Q4 20254,648$582.3K0.1%00.0%UnchangedHolders
Q3 20254,648$622.6K0.1%00.0%UnchangedHolders
Q2 20254,648$632.2K0.1%00.0%UnchangedHolders
Q1 20254,648$616.6K0.1%+2,000+75.5%AddedHolders
Q4 20242,648$299.5K<0.1%00.0%UnchangedHolders
Q3 20242,648$301.9K0.1%−200−7.0%ReducedHolders
Q2 20242,848$295.9K0.1%−37−1.3%ReducedHolders
Q1 20242,885$327.9K0.1%+200+7.4%AddedHolders
Q4 20232,685$295.5K0.1%00.0%UnchangedHolders
Q3 20232,685$260.0K0.1%00.0%UnchangedHolders
Q2 20232,685$292.7K0.1%00.0%UnchangedHolders
Q1 20232,685$271.9K0.1%−2,025−43.0%ReducedHolders
Q4 20224,710$517.1K0.1%00.0%UnchangedHolders
Q3 20224,710$456.0K0.1%−1,000−17.5%ReducedHolders
Q2 20225,710$620.0K0.2%−125−2.1%ReducedHolders
Q1 20225,835$691.0K0.2%00.0%UnchangedHolders
Q4 20215,835$821.0K0.2%00.0%UnchangedHolders
Q3 20215,835$687.0K0.2%00.0%UnchangedHolders
Q2 20215,835$676.0K0.2%−768−11.6%ReducedHolders
Q1 20216,603$792.0K0.2%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.